Results 71 to 80 of about 37,023 (237)

Targeting KRAS for cancer therapy

open access: yesBritish Journal of Pharmacology, EarlyView.
In recent years, therapeutics targeted against KRAS proto‐oncogene GTPase (KRAS)‐mutant cancers have seen significant progress. Herein we outline the biology and epidemiology of KRAS alterations at the lineage and allele levels, reviewing the clinical evidence for KRASG12C inhibition from the discovery of the recessive switch pocket to sotorasib ...
Jianlong Jia   +4 more
wiley   +1 more source

Impact of a Pediatric Nurse-Administered Mind-Body Relaxation Intervention on Mitigating Chemotherapy-Induced Nausea and Vomiting Among Hospitalized Children [PDF]

open access: yesEgyptian Journal of Health Care
Background: Chemotherapy-Induced Nausea and Vomiting (CINV) and treatment-related anxiety remain highly distressing side effects for pediatric oncology patients, often requiring rescue antiemetic medications.
Tanazor Hemdan Abdelhamed Morsi   +3 more
doaj   +1 more source

Chemotherapy-Induced Nausea and Vomiting

open access: yes, 2021
Chemotherapy-induced nausea and vomiting is a common adverse effect in cancer patients that not only impacts quality of life, but also treatment outcomes. The prevalence of nausea and vomiting is related to several factors, including the emetogenicity of the chemotherapy regimen, the dose and rate of administration of the chemotherapy agents, various ...
openaire   +2 more sources

Therapeutic access points: The roles of circumventricular organs in drug delivery and metabolic regulation

open access: yesBritish Journal of Pharmacology, EarlyView.
The current obesity drug landscape, dominated by GLP‐1 receptor agonists and emerging multi‐agonist therapies, has reinforced that long‐term weight loss is achieved in large part through central mechanisms that suppress appetite and reshape energy balance.
Ines Martinez‐Corral   +3 more
wiley   +1 more source

Reappraisal of the role of dolasetron in prevention and treatment of nausea and vomiting associated with surgery or chemotherapy

open access: yesCancer Management and Research, 2012
S Michael Roberts, Dmitri S Bezinover, Piotr K JanickiDepartment of Anesthesiology, Penn State College of Medicine, Penn State Milton S Hershey Medical Center, Hershey, PA, USAAbstract: Chemotherapy-induced nausea and vomiting and postoperative nausea ...
Janicki PK, Bezinover DS, Roberts SM
doaj  

Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics

open access: yes, 2016
Megan Brafford May,1 Ashley E Glode2 1Department of Pharmacy, Baptist Health Lexington, Lexington, KY, USA; 2Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus ...
May MB, Glode AE
core  

Investigation of the mechanisms and modulation of irinotecan‐induced emesis in Suncus murinus

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Irinotecan is a widely used chemotherapeutic agent that frequently causes nausea and emesis. Its emetic mechanism of action is poorly understood and the choice of drugs to reduce nausea and emesis is largely empirical. Experimental Approach Using Suncus murinus, we examined (i) the dose–response and temporal profile of ...
Zengbing Lu   +7 more
wiley   +1 more source

Effect Of Ginger Infusion On Chemotherapy Induced Nausea And Vomiting In Breast Cancer Patients [PDF]

open access: yes, 2013
Nausea and vomiting are the most common side effects of chemotherapy. Ginger is one of complementary therapy to treat nausea and vomiting. The purpose of this study was to determine the effect of ginger infuse for nausea and vomiting side effects of ...
Wahyu, Wedya   +2 more
core   +1 more source

Effect of Peppermint Inhalation on Chemotherapy Induced-Nausea and Vomiting in Children with Leukemia [PDF]

open access: yesAlexandria Scientific Nursing Journal
Background: Today, leukemia is one of the most important health challenges in the world. Despite the many advances in malignancy treatment, children undergoing chemotherapy are still suffering from deliberating side effects. So, pediatric oncology nurses
Eman Arafa Badr   +3 more
doaj   +1 more source

Comparison of intestinal histopathological changes following teclistamab, BCMA‐directed CAR T, CD19‐directed CAR T and rituximab therapies

open access: yesHistopathology, EarlyView.
This is a retrospective review of intestinal tract biopsies from patients treated with various cellular immunotherapies (BCMA and CD19‐directed CAR T, teclistamab and rituximab therapies). We found distinct but overlapping histologic patterns across treatment groups, with lamina propria plasma cell depletion, crypt apoptotic bodies and active ...
Olivia J Leung   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy